PAPER Gonzalez AI, Edwards LC, Thomas KR, Weigand AJ, Bordyug M, Brenner EK, Urias UA, Bangen KJ

Growth-associated protein 43 is associated with faster functional decline among amyloid-positive individuals with objectively defined subtle cognitive decline and mild cognitive impairment.

Neuropsychology. 2025 Mar;39(3):248-258. PubMed.

PAPER Lomi M, Geraci F, Del Seppia C, Dolciotti C, Del Carratore R, Bongioanni P

Biomarker Profile in Peripheral Blood Cells Related to Alzheimer's Disease.

Mol Neurobiol. 2025 Mar 10; Epub 2025 Mar 10 PubMed.

PAPER Lemche E, Hortobágyi T, Kiecker C, Turkheimer F

Neuropathological links between T2DM and LOAD: systematic review and meta-analysis.

Physiol Rev. 2025 Mar 10; Epub 2025 Mar 10 PubMed.

PAPER Li Z

Predicting amyloid proteins using attention-based long short-term memory.

PeerJ Comput Sci. 2025;11:e2660. Epub 2025 Feb 7 PubMed.

PAPER Cao J, Li B, Li X

Identification of Alzheimer's disease brain networks based on EEG phase synchronization.

Biomed Eng Online. 2025 Mar 9;24(1):32. PubMed.

PAPER Su J, Zhao L, Fu R, Tang Z

Linking Circadian Rhythms to Gut-Brain Axis Lipid Metabolism Associated With Endoplasmic Reticulum Stress in Alzheimer's Disease.

CNS Neurosci Ther. 2025 Mar;31(3):e70329. PubMed.

PAPER Weber M, Roth HL, Abramowitz A, Johnson KG

Developing Treatment Models for the Delivery of the Antiamyloid Therapy, Lecanemab: Considerations for Implementation of Lecanemab in Healthcare Systems.

Am J Geriatr Psychiatry. 2025 Feb 26; Epub 2025 Feb 26 PubMed.

PAPER Kiselica AM, Kaser AN, Webber TA, Small BJ, Benge JF

Development and Preliminary Validation of Standardized Regression-Based Change Scores as Measures of Transitional Cognitive Decline.

Arch Clin Neuropsychol. 2025 Mar 10; Epub 2025 Mar 10 PubMed.

PAPER Wada K

[Diagnostic Communication for Alzheimer's Disease].

Brain Nerve. 2025 Mar;77(3):251-257. PubMed.

PAPER Serpente M, Delvecchio G, Fenoglio C, Di Consoli L, Giudici G, Borracci V, Rotondo E, Arcaro M, Sacchi L, Pintus M, Ghezzi L, Ferro A, Prunas C, Callari A, Scola E, Triulzi FM, Arighi A, Brambilla P, Galimberti D

Differential miRNA expression in neural-enriched extracellular vesicles as potential biomarker for frontotemporal dementia and bipolar disorder.

Neurobiol Dis. 2025 Mar 8;:106867. Epub 2025 Mar 8 PubMed.

PAPER Yan X, Wang E, Zhao M, Ma G, Xu XX, Zhao JB, Li X, Zeng J, Ma X

Microbial infection instigates tau-related pathology in Alzheimer's disease via activating neuroimmune cGAS-STING pathway.

Neuroscience. 2025 Mar 9;572:122-133. Epub 2025 Mar 9 PubMed.

PAPER Puangmalai N, Aday AE, Samples M, Bhatt N, Cascio FL, Marcatti M, Park SJ, Fung L, Jerez C, Penalva LO, Zhao Y, Hao H, Lugano D, Kayed R, Montalbano M

Pathogenic Oligomeric Tau alters Neuronal RNA Processes through the Formation of Nuclear Heteromeric Amyloids with RNA-Binding Protein Musashi1.

Prog Neurobiol. 2025 Mar 8;:102742. Epub 2025 Mar 8 PubMed.

PAPER Lorenzini L, Barkhof F

The Transdiagnostic Value of Plasma Biomarkers for Neurodegenerative and Cerebrovascular MRI Findings.

Neurology. 2025 Apr 8;104(7):e213531. Epub 2025 Mar 10 PubMed.

PAPER Kubinski S, Claus L, Schüning T, Zeug A, Kalmbach N, Staege S, Gschwendtberger T, Petri S, Wegner F, Claus P, Hensel N

Aggregates associated with amyotrophic lateral sclerosis sequester the actin-binding protein profilin 2.

Hum Mol Genet. 2025 Mar 10; Epub 2025 Mar 10 PubMed.

PAPER Liou JJ, Li J, Berardinelli J, Jin H, Santini T, Noh J, Farhat N, Wu M, Aizenstein HJ, Mettenburg JM, Yong WH, Head E, Ikonomovic MD, Ibrahim TS, Kofler JK, Alzheimer Biomarker Consortium—Down Syndrome

Correlating hippocampal and amygdala volumes with neuropathological burden in Down syndrome and Alzheimer's disease and related neurodegenerative pathologies using 7T postmortem MRI.

J Neuropathol Exp Neurol. 2025 Mar 10; Epub 2025 Mar 10 PubMed.